RDMD raises $14M for rare disease real-world evidence generation
The San Francisco-based startup is one of several that have been raising money over the past couple of weeks in areas like neurology, oncology and women's health.
Obesity drug lorcaserin gets thumbs-down from FDA (Morning Read)
The Food and Drug Administration made it official Saturday, turning a thumbs-down to Lorqess (lorcaserin), the new diet drug by Arena Pharmaceuticals, because of concerns that it may cause tumors in rats and is marginally effective, according to the Pharmalot blog.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.